ABVC Biopharma Inc

詳細情報 ABVC Biopharma Inc 企業名

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on development products and technologies to combat various diseases. The Company develops its pipeline by tracking medical discoveries or medical device technologies in research institutions in the Asia-Pacific region. It has a pipeline of six drugs and one medical device under development. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1701, ABV-1519, and ABV-1703. ABV-1504 is a botanical reuptake inhibitor that targets norepinephrine to treat major depressive disorder (MDD). It is developing ABV-1505 for treating attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1701 is a vitreous substitute for vitrectomy. Its ABV-1519 is used for the treatment of non-small cell lung cancer. ABV-1703 is a drug for advanced, inoperable, or metastatic pancreatic cancer. The Company develops drugs and medical devices derived from plants.

企業情報

企業コードABVC

会社名ABVC Biopharma Inc

上場日Nov 09, 2004

最高経営責任者「CEO」Dr. Uttam Yashwant Patil

従業員数16

証券種類Ordinary Share

決算期末Nov 09

本社所在地44370 Old Warm Springs Blvd

都市FREMONT

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号94538-6148

電話番号15106680881

ウェブサイトhttps://abvcpharma.com/

企業コードABVC

上場日Nov 09, 2004

最高経営責任者「CEO」Dr. Uttam Yashwant Patil

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Shuling Jiang

Director

1.00M

+3.82%

Dr. Tsung-Shann (T.S.) Jiang, Ph.D.

Chief Scientific Officer, Chief Strategy Officer, Director

375.99K

-11.15%

Mr. Eugene Jiang

Chairman of the Board, Chief Business Officer

131.16K

--

Mr. Yoshinobu Odaira

Independent Director

57.76K

--

Dr. Chang-Jen Jiang, M.D.

Director

42.03K

-0.12%

Dr. Tsang Ming Jiang, Ph.D.

Director

41.99K

--

Ms. Yen-Hsin Chou

Independent Director

41.96K

--

Ms. Norimi Sakamoto

Independent Director

41.85K

--

Ms. Hsin-Hui Miao

Independent Director

41.51K

-13.66%

Mr. Yu- Min (Francis) Chung

Independent Director

41.39K

-1.33%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Shuling Jiang

Director

1.00M

+3.82%

Dr. Tsung-Shann (T.S.) Jiang, Ph.D.

Chief Scientific Officer, Chief Strategy Officer, Director

375.99K

-11.15%

Mr. Eugene Jiang

Chairman of the Board, Chief Business Officer

131.16K

--

Mr. Yoshinobu Odaira

Independent Director

57.76K

--

Dr. Chang-Jen Jiang, M.D.

Director

42.03K

-0.12%

Dr. Tsang Ming Jiang, Ph.D.

Director

41.99K

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Sat, May 17

株主統計

種類

株主統計

比率

Jiang (Shuling)

5.98%

YuanGene, Corp

4.95%

Jiang (Tsung-Shann)

2.24%

Jiang (Eugene)

0.78%

Geode Capital Management, L.L.C.

0.62%

Other

85.43%

株主統計

比率

Jiang (Shuling)

5.98%

YuanGene, Corp

4.95%

Jiang (Tsung-Shann)

2.24%

Jiang (Eugene)

0.78%

Geode Capital Management, L.L.C.

0.62%

Other

85.43%

種類

株主統計

比率

Individual Investor

11.52%

Corporation

4.95%

Investment Advisor

1.02%

Investment Advisor/Hedge Fund

0.81%

Venture Capital

0.36%

Hedge Fund

0.08%

Other

81.25%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

34

3.14M

18.75%

-459.62K

2025Q1

36

3.18M

25.48%

-443.49K

2024Q4

37

3.35M

25.84%

-140.63K

2024Q3

38

3.28M

25.33%

-177.84K

2024Q2

39

3.21M

27.30%

-361.06K

2024Q1

37

3.25M

30.84%

+1.04M

2023Q4

37

1.92M

24.18%

+3.24K

2023Q3

39

1.80M

52.80%

+194.05K

2023Q2

37

1.48M

44.76%

-133.59K

2023Q1

36

1.48M

44.98%

+2.69K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Jiang (Shuling)

1.00M

5.98%

+36.89K

+3.82%

Apr 28, 2025

YuanGene, Corp

829.70K

4.95%

--

May 27, 2025

Jiang (Tsung-Shann)

375.99K

2.24%

-47.17K

-11.15%

Apr 28, 2025

Jiang (Eugene)

131.16K

0.78%

--

May 27, 2025

Geode Capital Management, L.L.C.

104.48K

0.62%

+25.20K

+31.78%

Mar 31, 2025

The Lind Partners, LLC

94.99K

0.57%

-105.06K

-52.52%

Dec 31, 2024

Patil (Uttam)

72.43K

0.43%

--

Apr 28, 2025

XTX Markets LLC

60.44K

0.36%

+26.03K

+75.67%

Mar 31, 2025

Odaira (Yoshinobu)

57.76K

0.34%

--

Apr 28, 2025

The Vanguard Group, Inc.

46.95K

0.28%

--

Mar 31, 2025

詳細を見る

3.200USD

ABVC Biopharma Inc

3.200

概要

企業名

金融